OCUPHIRE PHARMA INC's ticker is OCUP and the CUSIP is 67577R102. A total of 15 filers reported holding OCUPHIRE PHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,856 | -22.2% | 2,942 | +0.8% | 0.00% | – |
Q2 2023 | $12,673 | +16.0% | 2,920 | +0.2% | 0.00% | – |
Q1 2023 | $10,928 | +6.3% | 2,914 | +0.1% | 0.00% | – |
Q4 2022 | $10,279 | +71.3% | 2,912 | +0.1% | 0.00% | – |
Q3 2022 | $6,000 | +20.0% | 2,908 | +0.1% | 0.00% | – |
Q2 2022 | $5,000 | -44.4% | 2,904 | +0.4% | 0.00% | – |
Q1 2022 | $9,000 | – | 2,892 | +2735.3% | 0.00% | – |
Q4 2021 | $0 | – | 102 | +52.2% | 0.00% | – |
Q3 2021 | $0 | – | 67 | +1575.0% | 0.00% | – |
Q2 2021 | $0 | – | 4 | 0.0% | 0.00% | – |
Q1 2021 | $0 | – | 4 | 0.0% | 0.00% | – |
Q4 2020 | $0 | – | 4 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Regency Capital Management Inc.\DE | 15,000 | $79,000 | 0.06% |
Ikarian Capital, LLC | 119,551 | $632,000 | 0.05% |
NORRIS PERNE & FRENCH LLP/MI | 78,909 | $417,000 | 0.04% |
OCCUDO QUANTITATIVE STRATEGIES LP | 23,445 | $124,000 | 0.02% |
Stokes Family Office, LLC | 12,120 | $64,000 | 0.01% |
MARSHALL WACE, LLP | 329,131 | $1,738,000 | 0.01% |
Cornerstone Capital, Inc. | 11,357 | $60,000 | 0.01% |
MCF Advisors LLC | 9,499 | $50,000 | 0.01% |
Cutler Group LLC / CA | 7,900 | $41,000 | 0.00% |
BOOTHBAY FUND MANAGEMENT, LLC | 13,389 | $71,000 | 0.00% |